Alumni raised $1.45B in 2022 - Download Free Report Now


Molecular FingerPrinting process for early-stage diagnosis of cancer, enabling point-of-care therapeutics based on gene regulation.

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of CeMines plus 5517 other startups.

Start Free 7 Day Trial Now

Learn More About CeMines

Technology/product details

CEO presentation

Competing Startups


Companies We Work With